| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.3 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.3 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |